Leading European and international specialists will meet in Lisbon from 27–28 June to take stock of the global new drugs phenomenon. The Third international multidisciplinary forum on new drugs, organised by the EU drugs agency (EMCDDA), in cooperation with Europol, will gather over 100 participants from some 40 countries.

The event will build on the results of the Second interdisciplinary forum on new and emerging psychoactive substances, co-hosted by the EMCDDA and NIDA in Palm Springs in June 2012, and the First international multidisciplinary forum on new drugs, organised by the EMCDDA in Lisbon in May 2011. These events focused on the growing global nature of the phenomenon and the importance of international cooperation in responding to the issue.

Commenting ahead of this year’s forum, EMCDDA Director Wolfgang Götz says: ‘Only a few years ago, new drugs were generally regarded as being of limited significance to drug policy. The continued growth of the market, however — particularly driven by “legal highs” — has seen the issue develop into a complex policy challenge that is now of major international concern’.

Read here more information about the event.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.